CNTNAP3 and depressive symptom measurement: The results showed that Cntnap3 knockdown reduced anxiety‐ and depression‐like behaviors, as evidenced by decreased jump counts in the OFT (Figure 5E; Figure S9A, Supporting Information) and reduced immobility duration in the FST (Figure 5F).